Processa Pharmaceuticals Stock Market Value
| PCSA Stock | USD 1.02 0.04 4.08% |
| Symbol | Processa |
Processa Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Processa Pharmaceuticals. If investors know Processa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Processa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.80) | Return On Assets (1.13) | Return On Equity (2.12) |
The market value of Processa Pharmaceuticals is measured differently than its book value, which is the value of Processa that is recorded on the company's balance sheet. Investors also form their own opinion of Processa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Processa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Processa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Processa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Processa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Processa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Processa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Processa Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Processa Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Processa Pharmaceuticals.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Processa Pharmaceuticals on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Processa Pharmaceuticals or generate 0.0% return on investment in Processa Pharmaceuticals over 30 days. Processa Pharmaceuticals is related to or competes with Alpha Cognition, Acurx Pharmaceuticals, Fennec Pharmaceuticals, SAB Biotherapeutics, Third Harmonic, Eliem Therapeutics, and Inhibrx. Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products ... More
Processa Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Processa Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Processa Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 20.99 | |||
| Value At Risk | (5.34) | |||
| Potential Upside | 6.2 |
Processa Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Processa Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Processa Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Processa Pharmaceuticals historical prices to predict the future Processa Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.67) | |||
| Total Risk Alpha | (1.14) | |||
| Treynor Ratio | (0.43) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Processa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Processa Pharmaceuticals Backtested Returns
Processa Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11% return per unit of risk over the last 3 months. Processa Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Processa Pharmaceuticals' Coefficient Of Variation of (766.19), variance of 15.58, and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide. The company holds a Beta of 1.21, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Processa Pharmaceuticals will likely underperform. At this point, Processa Pharmaceuticals has a negative expected return of -0.45%. Please make sure to check Processa Pharmaceuticals' potential upside, as well as the relationship between the accumulation distribution and day median price , to decide if Processa Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.79 |
Good predictability
Processa Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Processa Pharmaceuticals time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Processa Pharmaceuticals price movement. The serial correlation of 0.79 indicates that around 79.0% of current Processa Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.79 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Processa Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Processa Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Processa Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Processa Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Processa Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Processa Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Processa Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Processa Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Processa Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Processa Pharmaceuticals Lagged Returns
When evaluating Processa Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Processa Pharmaceuticals stock have on its future price. Processa Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Processa Pharmaceuticals autocorrelation shows the relationship between Processa Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Processa Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Processa Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Processa Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Processa Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Processa Pharmaceuticals Stock:Check out Processa Pharmaceuticals Correlation, Processa Pharmaceuticals Volatility and Processa Pharmaceuticals Alpha and Beta module to complement your research on Processa Pharmaceuticals. For information on how to trade Processa Stock refer to our How to Trade Processa Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Processa Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.